TherapeuticsMD (TXMD) Current Leases (2019 - 2020)
TherapeuticsMD (TXMD) posted Current Leases of $2.3 million for Q4 2020, down 6.25% on a QoQ basis from $2.4 million in Q3 2020, and up 50.11% year-over-year from $1.5 million in Q1 2020.
TherapeuticsMD (TXMD) Current Leases (2019 - 2020) Analysis & Trends
TherapeuticsMD's Current Leases history runs 2 years deep, the most recent figure standing at $2.3 million for Q4 2020.
- Quarterly Current Leases rose 50.11% year-over-year to $2.3 million in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $2.3 million (up 50.11% YoY) and the FY2020 annual result came in at $2.3 million, up 50.11% from the prior year.
- Current Leases was $2.3 million for Q4 2020 at TherapeuticsMD, down from $2.4 million in the prior quarter.
- Across five years, Current Leases topped out at $2.4 million in Q3 2020 and bottomed at $1.2 million in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | TherapeuticsMD | 280,159.99 | -8.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 2.25 Mn |
| Sep 30, 2020 | 2.40 Mn |
| Jun 30, 2020 | 2.11 Mn |
| Mar 31, 2020 | 1.75 Mn |
| Dec 31, 2019 | 1.50 Mn |
| Sep 30, 2019 | 1.24 Mn |
| Mar 31, 2019 | 1.16 Mn |